Antibiotic conversion of intravenous to oral route
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty, Covilhã, Portugal)
- Co-author(s): Rafaela Barata:Health Science Faculty,University of Beira Interior,Covilhã,Portugal|Sarah Pousinho:Health Science Faculty,University of Beira Interior,Covilhã,Portugal|Ema Paulino:,Portuguese Pharmaceutical Society,Lisbon,Portugal|Manuel Morgado:Health Science Faculty,University of Beira Interior,Covilhã,Portugal;Pharmaceutical Services,Hospital Centre of Cova da Beira,Covilhã,Portugal
Antibiotic intravenous (IV) therapy implies higher costs, discomfort for the patient and risk of complications when compared to oral therapy. The conversion of IV to oral therapy (CIVO) becomes beneficial to all levels, from the hospital management to the comfort of the patient himself. The pharmacist's role becomes crucial as responsible.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.